Ultrasound-based "CEUS-Bosniak"classification for cystic renal lesions: an 8-year clinical experience
Standard
Ultrasound-based "CEUS-Bosniak"classification for cystic renal lesions: an 8-year clinical experience. / Herms, Elena; Weirich, Gregor; Maurer, Tobias; Wagenpfeil, Stefan; Preuss, Stephanie; Sauter, Andreas; Heck, Matthias; Gärtner, Anita; Hauner, Katharina; Autenrieth, Michael; Kübler, Hubert P; Holzapfel, Konstantin; Schwarz-Boeger, Ulrike; Heemann, Uwe; Slotta-Huspenina, Julia; Stock, Konrad Friedrich.
In: WORLD J UROL, Vol. 41, No. 3, 03.2023, p. 679-685.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Ultrasound-based "CEUS-Bosniak"classification for cystic renal lesions: an 8-year clinical experience
AU - Herms, Elena
AU - Weirich, Gregor
AU - Maurer, Tobias
AU - Wagenpfeil, Stefan
AU - Preuss, Stephanie
AU - Sauter, Andreas
AU - Heck, Matthias
AU - Gärtner, Anita
AU - Hauner, Katharina
AU - Autenrieth, Michael
AU - Kübler, Hubert P
AU - Holzapfel, Konstantin
AU - Schwarz-Boeger, Ulrike
AU - Heemann, Uwe
AU - Slotta-Huspenina, Julia
AU - Stock, Konrad Friedrich
N1 - © 2022. The Author(s).
PY - 2023/3
Y1 - 2023/3
N2 - PURPOSE: Renal cysts comprise benign and malignant entities. Risk assessment profits from CT/MRI imaging using the Bosniak classification. While Bosniak-IIF, -III, and -IV cover complex cyst variants, Bosniak-IIF and -III stand out due to notorious overestimation. Contrast-enhanced ultrasound (CEUS) is promising to overcome this deficit but warrants standardization. This study addresses the benefits of a combined CEUS and CT/MRI evaluation of renal cysts. The study provides a realistic account of kidney tumor boards' intricacies in trying to validate renal cysts.METHODS: 247 patients were examined over 8 years. CEUS lesions were graded according to CEUS-Bosniak (IIF, III, IV). 55 lesions were resected, CEUS-Bosniak- and CT/MRI-Bosniak-classification were correlated with histopathological diagnosis. Interobserver agreement between the classifications was evaluated statistically. 105 lesions were followed by ultrasound, and change in CEUS-Bosniak-types and lesion size were documented.RESULTS: 146 patients (156 lesions) were included. CEUS classified 67 lesions as CEUS-Bosniak-IIF, 44 as CEUS-Bosniak-III, and 45 as CEUS-Bosniak-IV. Histopathology of 55 resected lesions revealed benign cysts in all CEUS-Bosniak-IIF lesions (2/2), 40% of CEUS-Bosniak-III and 8% of CEUS-Bosniak-IV, whereas malignancy was uncovered in 60% of CEUS-Bosniak-III and 92% of CEUS-Bosniak-IV. Overall, CEUS-Bosniak-types matched CT/MRI-Bosniak types in 58% (fair agreement, κ = 0.28). CEUS-Bosniak resulted in higher stages than CT/MRI-Bosniak (40%). Ultrasound follow-up of 105 lesions detected no relevant differences between CEUS-Bosniak-types concerning cysts size. 99% of lesions showed the same CEUS-Bosniak-type.CONCLUSION: The CEUS-Bosniak classification is an essential tool in clinical practice to differentiate and monitor renal cystic lesions and empowers diagnostic work-up and patient care.
AB - PURPOSE: Renal cysts comprise benign and malignant entities. Risk assessment profits from CT/MRI imaging using the Bosniak classification. While Bosniak-IIF, -III, and -IV cover complex cyst variants, Bosniak-IIF and -III stand out due to notorious overestimation. Contrast-enhanced ultrasound (CEUS) is promising to overcome this deficit but warrants standardization. This study addresses the benefits of a combined CEUS and CT/MRI evaluation of renal cysts. The study provides a realistic account of kidney tumor boards' intricacies in trying to validate renal cysts.METHODS: 247 patients were examined over 8 years. CEUS lesions were graded according to CEUS-Bosniak (IIF, III, IV). 55 lesions were resected, CEUS-Bosniak- and CT/MRI-Bosniak-classification were correlated with histopathological diagnosis. Interobserver agreement between the classifications was evaluated statistically. 105 lesions were followed by ultrasound, and change in CEUS-Bosniak-types and lesion size were documented.RESULTS: 146 patients (156 lesions) were included. CEUS classified 67 lesions as CEUS-Bosniak-IIF, 44 as CEUS-Bosniak-III, and 45 as CEUS-Bosniak-IV. Histopathology of 55 resected lesions revealed benign cysts in all CEUS-Bosniak-IIF lesions (2/2), 40% of CEUS-Bosniak-III and 8% of CEUS-Bosniak-IV, whereas malignancy was uncovered in 60% of CEUS-Bosniak-III and 92% of CEUS-Bosniak-IV. Overall, CEUS-Bosniak-types matched CT/MRI-Bosniak types in 58% (fair agreement, κ = 0.28). CEUS-Bosniak resulted in higher stages than CT/MRI-Bosniak (40%). Ultrasound follow-up of 105 lesions detected no relevant differences between CEUS-Bosniak-types concerning cysts size. 99% of lesions showed the same CEUS-Bosniak-type.CONCLUSION: The CEUS-Bosniak classification is an essential tool in clinical practice to differentiate and monitor renal cystic lesions and empowers diagnostic work-up and patient care.
U2 - 10.1007/s00345-022-04094-0
DO - 10.1007/s00345-022-04094-0
M3 - SCORING: Journal article
C2 - 35986781
VL - 41
SP - 679
EP - 685
JO - WORLD J UROL
JF - WORLD J UROL
SN - 0724-4983
IS - 3
ER -